LYZZ Capital is a global healthcare-focused venture capital/private equity firm investing in talents, assets, and technologies globally, with a strong focus on addressing unmet medical needs and leveraging China’s large market potential. The firm combines experienced professionals from leading pharmaceutical/biotech companies and Wall Street, with over 20 years of combined biotech investment experience, including 15 years in China.
Preferred startup development maturity for initial funding deployment.
Global healthcare investments with emphasis on unmet medical needs and large market potential in China
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...